Sue Behrens, PhD is a biologics and vaccine manufacturing expert with 30+ years experience in cGMP manufacturing environments. Her global experience encompasses all aspects of scale-up and production of sterile vaccine & biopharmaceutical products and provides vaccine and biopharmaceutical manufacturing consulting services for bulk Drug Substance and aseptic filling of Drug Products. She provides market assessments/due diligence for novel technology and business opportunities for clients as well as CMC regulatory support for EMA/FDA submissions for sterile products.
Prior to consulting, she oversaw sterile process technology and engineering functions at Merck’s largest site, including the launch of four new products. She also led Merck-Schering Plough’s biologics science integration efforts. Ultimately, Behrens provided biologics manufacturing technology leadership at multiple development and manufacturing sites worldwide. She maintains affiliations with the International Society of Pharmaceutical Engineers, Women in Bio, and BioProcess International organizations.
EDUCATION
University of California, Berkeley
PhD, Chemical Engineering
University of Michigan
BSE, Chemical Engineering